1. Home
  2. WVE vs HIVE Comparison

WVE vs HIVE Comparison

Compare WVE & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.04

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

HIVE

HIVE Digital Technologies Ltd.

HOLD

Current Price

$2.84

Market Cap

1.1B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
HIVE
Founded
2012
1987
Country
Singapore
United States
Employees
317
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
WVE
HIVE
Price
$6.04
$2.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
8
Target Price
$29.81
$6.44
AVG Volume (30 Days)
2.2M
14.7M
Earning Date
04-28-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
$297,791,000.00
Revenue This Year
N/A
$169.51
Revenue Next Year
$85.67
$39.45
P/E Ratio
N/A
N/A
Revenue Growth
149.43
158.32
52 Week Low
$5.02
$1.73
52 Week High
$21.73
$7.84

Technical Indicators

Market Signals
Indicator
WVE
HIVE
Relative Strength Index (RSI) 53.05 41.16
Support Level $5.49 $2.64
Resistance Level $6.21 $3.40
Average True Range (ATR) 0.25 0.21
MACD 0.03 0.01
Stochastic Oscillator 83.54 28.57

Price Performance

Historical Comparison
WVE
HIVE

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HIVE HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers. Its computing power is used for high-performance computing (HPC) and for generating hashrate sold to mining pools for cryptocurrency mining. The Company uses cash flow from its hashrate services business to support the expansion of its AI and HPC operations through its subsidiary. The Company focuses on Canada, Sweden, and Paraguay, where low-cost renewable power supports its operations and expansion. It operates in one segment with two revenue streams: the mining and sale of digital currencies and high-performance computing hosting. The majority of its revenue is generated from Bermuda.

Share on Social Networks: